Ingersoll Rand Q3 revenue esges above estimates on orders growth

Reuters
2025/10/31
<a href="https://laohu8.com/S/IR">Ingersoll Rand</a> Q3 revenue esges above estimates on orders growth 

Overview

  • Ingersoll Rand Q3 revenue grows 5% yr/yr, beating analyst expectations, per LSEG data

  • Adjusted EBITDA for Q3 beats consensus, reflecting operational excellence

  • Company repurchased $193 mln in shares, returning value to shareholders

Outlook

  • Ingersoll Rand sees full-year 2025 revenue growth of 4-6%

  • Company expects 2025 organic revenue growth of (2)% to 0%

  • Adjusted EBITDA for 2025 projected at $2,060M - $2,090M

  • Ingersoll Rand anticipates 2025 adjusted EPS of $3.25 - $3.31

Result Drivers

  • ORGANIC ORDERS GROWTH - Co reports positive organic orders growth across both segments, highlighting resilience and operational excellence

  • INDUSTRIAL SEGMENT CHALLENGES - IT&S segment faced organic revenue decline due to volume declines, tariff impacts, and commercial investments

  • PRECISION SEGMENT GROWTH - P&ST segment achieved organic orders growth and improved margins, driven by Precision Technologies and Life Sciences

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

$1.95 bln

$1.94 bln (10 Analysts)

Q3 EPS

$0.61

Q3 Net Income

$245.80 mln

Q3 Adjusted EBITDA

Beat

$545 mln

$540.46 mln (9 Analysts)

Q3 Gross Profit

$855.20 mln

Q3 Operating Income

$375.50 mln

Q3 Pretax Profit

$319.40 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 9 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the industrial machinery & equipment peer group is "buy"

  • Wall Street's median 12-month price target for Ingersoll Rand Inc is $90.50, about 11.9% above its October 29 closing price of $79.70

Press Release: ID:nBw7F7st0a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10